ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Uangel Corporation

Uangel Corporation (072130)

0.00
0.00
(0.00%)
Closed August 07 2:30AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
-
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

072130 Latest News

Bristol Myers Squibb and Turning Point Therapeutics Announce Expiration of HSR Act Waiting Period and Clearance from Federal Cartel Office of Germany Related to Pending Acquisition of Turning Point Therapeutics

Bristol Myers Squibb (NYSE:BMY) and Turning Point Therapeutics, Inc. (NASDAQ:TPTX) (“Turning Point”) today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust...

Turning Point Therapeutics Reports Second-Quarter 2022 Financial Results, Provides Operational Updates

Positive feedback from pre-new drug application (NDA) meeting with U.S. Food and Drug Administration (FDA) focused on TRIDENT-1 registrational study of repotrectinibInitiated the Phase 1b/2...

Turning Point Therapeutics Provides Regulatory Update for Repotrectinib for the Treatment of ROS1+ Advanced NSCLC

SAN DIEGO, July 27, 2022 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a clinical-stage precision oncology company designing and developing novel targeted therapies for...

Turning Point Therapeutics and MD Anderson Announce Strategic Alliance to Advance Precision Cancer Therapies

HOUSTON and SAN DIEGO, June 24, 2022 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a clinical-stage precision oncology company designing and developing novel targeted...

Turning Point Therapeutics Shares Surge on Bristol Myers Deal

By Colin Kellaher Shares of Turning Point Therapeutics Inc. took flight on Friday after the clinical-stage precision-oncology company agreed to be acquired by Bristol Myers Squibb Co. for $4.1...

Bristol Myers to Buy Turning Point Therapeutics for $4.1 Billion

By Colin Kellaher Bristol Myers Squibb Co. on Friday said it agreed to buy clinical-stage precision-oncology company Turning Point Therapeutics Inc. for $4.1 billion, or $76 a share, in cash. The...

Turning Point Therapeutics to Participate in Upcoming Investor Conferences

SAN DIEGO, May 26, 2022 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a clinical-stage precision oncology company designing and developing novel targeted therapies for...

Turning Point Therapeutics Announces Appointment of Steve Sabus as Chief Commercial Officer

SAN DIEGO, May 16, 2022 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a clinical-stage precision oncology company designing and developing novel targeted therapies for...

Turning Point Therapeutics Reports First-Quarter 2022 Financial Results, Provides Operational Updates

Granted Third Breakthrough Therapy Designation (BTD) for Repotrectinib for the treatment of patients with ROS1-positive Metastatic NSCLC who have been Previously Treated with One ROS1 TKI and who...

Turning Point Gets Another FDA Breakthrough Designation for Repotrectinib

By Colin Kellaher Turning Point Therapeutics Inc. on Tuesday said the U.S. Food and Drug Administration granted breakthrough-therapy designation to its lead drug candidate, repotrectinib, for...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.

Discussion

View Full Feed
rolvram rolvram 5 minutes ago
Rosenblatt reiterates $200 price target on Nvidia.

Usually I don’t put much weight into these analyst upgrades but this specific analyst, Hans Mosesmann, is the #2 ranked analyst on Wall Street.

I’d say that means something.

https://x.com/ZaStocks/status/
NVDA
Jack_Herer Jack_Herer 5 minutes ago
LOL. I’ve got 25 years in west African gold, from exploration to mining. For real companies though, not scammers. Though I’ve met plenty of scammers in this business…
HIRU
Seminole Red Seminole Red 5 minutes ago
yep, me too
janice shell janice shell 6 minutes ago
...they submit information to be added and mods then add the information if it checks out.

I believe you seriously overestimate the ability of many members to conduct research, or evaluate research conducted by others.
arizona1 arizona1 6 minutes ago
Oh the joy!

Where The Hell Are All Trump's Rallies? He's Got ONE Scheduled. In Montana!

https://cdn.prod.dailykos.com/images/1331294/story_image/GUVgTHNXYAA4hZz.jpeg?1723035867

VP Harris begins a 7 swing-state campaign tour over five days. Trump has ONE s
ShawnP123 ShawnP123 7 minutes ago
But the company did say still on track for ramped up delivery in 2nd half which isn't true according to most of the publications which give a 3 month min for testing and determining what the problem is especially if it requires a mask change which would be more like 5-6 months to generate masks, the
NVDA
GetSeriousOK GetSeriousOK 7 minutes ago
So you think "the device has really changed?" (Emphasis mine)

How has it "really changed?"

The patents were all pre-2014 so the patents were for the version you show in your picture. Also, any clinicals done before 2014 were done with the version you show in your pictu
BIEL
drugmanrx drugmanrx 7 minutes ago
And who withdrew it , THE CEO JASON TUCKER.

In fact the Form 10 registration was withdrawn

Not Jason Black.

To whom it may concern:

Please be advised that Cann American Corp. (“CNNA”, the “Company”) respectfully requests the withdrawal of
CNNA
JNdouble1 JNdouble1 7 minutes ago
Actually, it does look just about the same. ( a picture of the old square patch would have been more effective)

The differences are cosmetic, and minor. The context, which you are outside of, was Sree Koneru and his expertise as a biomedical engineer.

The device did not
BIEL
pinkslipjunkie pinkslipjunkie 7 minutes ago
How you been doing NYbob...and that is good to see....not saying all Islamic...but for the most part...they are not very Christian.
100,000 PEOPLE PROTESTING AGAINST ISLAMIC INVASION OF ENGLAND - TOMMY ROBINSON
gawti88 gawti88 8 minutes ago
markets rocky, dont matter, this can turn instantly. You'll see.
CEOS
mascale mascale 8 minutes ago
Versus a gutter low-life reading of Kalisma/Hiru venture, then ASM includes smaller actual mining operations in the category as well as the prospector level people. The gutter low-life reading of Liberian licensing records overlooks international companies, including Kalisma. Those are public info
ASM
frrol frrol 9 minutes ago
Deeply neurotic; likely not clinically insane. And a fool.
You're just catching on?
AVXL
Milesblue42 Milesblue42 9 minutes ago
DILUTION: Ronn-Ford now has 1,174,787,746 shares outstanding

There were 1.09 Billion shares before if I'm not mistaken. Now there are 1,174,787,746 Billion shares

https://www.otcmarkets.com/stock/RONN/security
RONN
louieforpar louieforpar 9 minutes ago
Swifties

https://t.co/F4DlU3fkc9


Is this real!!!!!

https://t.co/jWKlhHrOyx


Seriously, can you even imagine Trump doing this with Barron or Tiffany?


https://t.co/2PcNRmzHwJ
creede creede 10 minutes ago
I should probably join you in that pursuit.

Got a list of microcaps you like to trade?

rolvram rolvram 10 minutes ago
Nvidia, AMD Stocks Present 'Tremendous Opportunity' After Recent Losses, Analysts Say
By Naomi Buchanan Published August 07, 2024 05:10 PM EDT
Nvidia, AMD
Bloomberg / Contributor / Getty Images

Key Takeaways
Recent losses for Nvidia and Advanced Micro Devic
AMD NVDA
tiger_trader tiger_trader 10 minutes ago
And is that a price increase that grows organically w/o a RS?
IGPK
waterchaser waterchaser 10 minutes ago
Then you haven’t been paying attention, brah.
HIRU
capgain capgain 10 minutes ago
There ya go, Flo!

Your Recent History

Delayed Upgrade Clock